Products

Products

Home page

Drug Products

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

← BACK Return

Propylgallate Injection 5ml: 60mg

【Drug Name】

Generic Name：Propylgallate Injection

【Strength】

5ml: 60mg

【Approval Status】

NMPA approval No.: H20050377

【Indication】

To prevent and treat cerebral thrombosis, coronary heart disease, and complications after surgery-thrombosis deep phlebitis.

Refers to drug instructions for details.

VIWIT

Drug and Medical Device Internet Information Service Filing Number: 沪网药信备字〔2025〕00283号

Internet Information Service Filing Number: 沪ICP备12014533号

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search